Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02681965 · ClinicalTrials.gov registry record · NA

A Mail and Video-based Weight Loss Trial in Breast Cancer Survivors

A NA study of Obesity and Breast Cancer Survivorship, sponsored by Yale University.

Completed
Registry status
NA
Development phase
205
Enrollment target
1
Study location

NCT02681965: Completed NA study of Obesity and Breast Cancer Survivorship, sponsored by Yale University.

NCT02681965 is a NA study of Obesity and Breast Cancer Survivorship that has completed, run by Yale University. The registered enrollment target is 205 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02681965, a NA study of Obesity and Breast Cancer Survivorship, has completed, sponsored by Yale University.

COMPLETED
Registry status
NA
Development phase
205 participants
Enrollment target
1
Study location

Study Summary

Proposed is a 6-month randomized controlled trial, in 200 overweight or obese Stage I-IIIC breast cancer survivors examining 6-month changes in: 1) body weight, 2) diet, 3) physical activity, and 4)quality of life in women randomized to receive the modified LEAN intervention compared to women randomized to wait-list control (i.e., the wait-list control will receive the modified LEAN intervention after completing the 6-month study).

Primary Outcome

A standard digital scale will be mailed to each participant along with the baseline packet to allow consistent measurement of weight by participants. Participants will weigh themselves. Body weight will be collected in kilograms (kg).

Interventions

  • BEHAVIORAL LEAN book/videos

Study Locations (1)

Connecticut

  • Yale University - New Haven

Trial Details

FieldValue
Enrollment Target 205 participants
Start Date 2016-03
Est. Completion 2018-04-01
Phase NA
Yale University

1,492 total trials

What the finished NCT02681965 record still lists

NCT02681965 is an interventional study that assigns participants to a tested intervention. The registered 205 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (75% lower).

The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which LEAN book/videos is the first listed.

NCT02681965 reports a single indexed study location in Connecticut.

Frequently Asked Questions

What is clinical trial NCT02681965 about?

NCT02681965 is a clinical study titled "A Mail and Video-based Weight Loss Trial in Breast Cancer Survivors". Proposed is a 6-month randomized controlled trial, in 200 overweight or obese Stage I-IIIC breast cancer survivors examining 6-month changes in: 1) body weight, 2) diet, 3) physical activity, and 4)quality of life in women randomized to receive the modified LEAN intervention compared to women random...

What is the current status of trial NCT02681965?

This trial is currently completed. It is a NA study. The enrollment target is 205 participants. The study started on 2016-03. Estimated completion is 2018-04-01.

What conditions does trial NCT02681965 study?

This clinical trial studies the following conditions: Obesity, Breast Cancer Survivorship.

What interventions are being tested in trial NCT02681965?

The interventions under investigation include: LEAN book/videos (BEHAVIORAL).

Who is sponsoring clinical trial NCT02681965?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02681965 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02681965's enrollment target sits among peer trials

205 310th of 1053 higher than 743 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03457493 · 205 participants · Phase 1

    The University of Alabama At Birmingham (UAB) Neuroinflammation in Parkinson's Disease-TSPO- Positron Emission Tomography (PET) Substudy

  • NCT05134857 · 205 participants · Phase 2

    The Zonisamide and Reinforcement for Reducing Alcohol Use (ZARRA) Study

  • NCT05181891 · 205 participants · Phase 2

    Pharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking

  • NCT05283811 · 205 participants · NA

    Understanding Prefrontal and Medial Temporal Neuronal Responses to Algorithmic Cognitive Variables in Epilepsy Patients

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02681965, the US trial registry maintained by the National Library of Medicine. NCT02681965 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.